Bloomberg — Sigma Pharmaceuticals Ltd., the Australian drugmaker that lost half its market value after reporting a record loss last month, said Chief Executive Officer and Managing Director Elmo de Alwis resigned.
| Read at Bloomberg |
| Read at The Australian |
| Read at Sydney Morning Herald |
Related posts:
- Australian code of good manufacturing practice for medicinal products
- Analytical Instrumentation – Performance Characteristics & Quality: Performance Characteristics and Quality
- Early exposure to porn increases STDs risk
- AVEO Pharmaceuticals, Inc. (AVEO) Receives $5 Million Milestone Payment from Biogen Idec, Inc. (Massachusetts) (BIIB) Under Licensing Agreement for ErbB3 Antibody Program
- Kinex Pharmaceuticals To Present At 101st Annual Meeting Of AACR
Join hundreds of students and get all book resources for FREE! Subscribe to Pharmacy E-books via RSS or via E-mail
